The patented drug Efavirenz (used for the treatment of AIDS) has been compulsorily licensed by the Government of Brazil (http://www.businessday.co.za/articles/world.aspx?ID=BD4A454667).
Merck's response to what it calls "misappropriation" (which it certainly is not - under the laws of Brazil) of its intellectual property, is not yet known.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment